Northwestern Mutual Wealth Management
PBYI icon

Northwestern Mutual Wealth Management’s Puma Biotechnology PBYI Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50
Closed – – 2603
2020
Q1 		$0 Hold
50
– – ﹤0.01% 2699
2019
Q4 		$0 Hold
50
– – ﹤0.01% 2560
2019
Q3 		$1K Hold
50
– – ﹤0.01% 2380
2019
Q2 		$1K Hold
50
– – ﹤0.01% 2425
2019
Q1 		$2K Hold
50
– – ﹤0.01% 2327
2018
Q4 		$1K Hold
50
– – ﹤0.01% 2303
2018
Q3 		$2K Hold
50
– – ﹤0.01% 2302
2018
Q2 		$3K Hold
50
– – ﹤0.01% 2107
2018
Q1 		$3K Hold
50
– – ﹤0.01% 1994
2017
Q4 		$5K Hold
50
– – ﹤0.01% 1932
2017
Q3 		$6K Hold
50
– – ﹤0.01% 1788
2017
Q2 		$4K Buy
+50
New +$2.8K ﹤0.01% 1786
2015
Q1 		– Sell
-17
Closed -$3K – 1737
2014
Q4 		$3K Buy
+17
New +$3.77K ﹤0.01% 1426

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Northwestern Mutual Wealth Management's PBYI Position: Q2 2020 in Review

Northwestern Mutual Wealth Management sold out of Puma Biotechnology (PBYI) in Q2 2020, closing a stake of 50 shares.

Northwestern Mutual Wealth Management first reported a position in PBYI in Q4 2014 and held it in 13 quarters. The position peaked at $6K in Q3 2017. 128 funds tracked by Wall St. Rank hold PBYI as of Q2 2020.

  • Northwestern Mutual Wealth Management reported no remaining Puma Biotechnology position as of Q2 2020 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 50 Puma Biotechnology shares in Q2 2020.
  • Northwestern Mutual Wealth Management first reported a position in Puma Biotechnology in Q4 2014 and held it in 13 quarters.
  • Northwestern Mutual Wealth Management's Puma Biotechnology position peaked at $6K in Q3 2017.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2020.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.